FDA approves GEs cardiovascular US system

Twitter icon
Facebook icon
LinkedIn icon
e-mail icon
Google icon

The FDA has cleared the latest version of GE Healthcare’s Vivid E9 cardiovascular ultrasound system.

Dubbed the Vivid E9 Breakthrough 2012, the system includes a 4D transducer for transesophageal echocardiography and tools designed to improve workflow. Currently, Vivid E9 is used most frequently in the echo lab, but the additions in the latest version enable the system’s use in settings such as the cath lab or operating room, according to GE.

Other procedures supported by the addition of the 4D transducer are mitral valve repair, transcatheter aortic valve repair, atrial septal defect closures and patent foraman ovale closures.